LiZhu Pharmaceuticals (01513): NS-041 tablets for the treatment of depression have obtained a drug clinical trial approval letter for new indications.

Wisdom Financial News APP reports that Lee's Pharmaceutical (01513) announced that its wholly-owned subsidiary Lee's Group Lee's Pharmaceutical Factory (Lee's Pharmaceutical Factory) has received the Drug Clinical Trial Approval Notice (Notice No.: 2025LP03436, 2025LP03437) issued by the National Medical Products Administration regarding the addition of the indication for treating depression for the drug NS-041 tablets, and has approved the clinical trial for the additional indication of NS-041 tablets.